PD-1 inhibition restructures the tumor microenvironment: re-energized CTLs secrete IFN-γ that polarizes macrophages towards an M1 phenotype and stimulates stromal cells to secrete the chemokines CXCL9/10, which additionally attract NK cells to the tumor [125]. The gene discussed is PDCD1; the disease is neoplasm.